News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,961 Results
Type
Article (51698)
Company Profile (317)
Press Release (652944)
Multimedia
Podcasts (122)
Webinars (17)
Section
Business (199056)
Career Advice (2646)
Deals (36824)
Drug Delivery (125)
Drug Development (82016)
Employer Resources (164)
FDA (17357)
Job Trends (15123)
News (344961)
Policy (34207)
Tag
Academia (2655)
Academic (1)
Accelerated approval (7)
Adcomms (32)
Allergies (96)
Alliances (51785)
ALS (109)
Alzheimer's disease (1515)
Antibody-drug conjugate (ADC) (178)
Approvals (17303)
Artificial intelligence (336)
Autoimmune disease (32)
Automation (18)
Bankruptcy (350)
Best Places to Work (11407)
BIOSECURE Act (22)
Biosimilars (123)
Biotechnology (189)
Bladder cancer (93)
Brain cancer (34)
Breast cancer (358)
Cancer (2781)
Cardiovascular disease (226)
Career advice (2214)
Career pathing (34)
CAR-T (194)
CDC (33)
Cell therapy (524)
Cervical cancer (20)
Clinical research (67017)
Collaboration (996)
Company closure (3)
Compensation (639)
Complete response letters (29)
COVID-19 (2790)
CRISPR (63)
C-suite (301)
Cystic fibrosis (113)
Data (2765)
Decentralized trials (2)
Denatured (34)
Depression (63)
Diabetes (318)
Diagnostics (6587)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (143)
Drug pricing (144)
Drug shortages (34)
Duchenne muscular dystrophy (116)
Earnings (78595)
Editorial (48)
Employer branding (20)
Employer resources (147)
Events (109045)
Executive appointments (844)
FDA (18914)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (869)
Gene editing (139)
Generative AI (28)
Gene therapy (395)
GLP-1 (867)
Government (4270)
Grass and pollen (6)
Guidances (176)
Healthcare (18143)
Huntington's disease (29)
IgA nephropathy (39)
Immunology and inflammation (166)
Immuno-oncology (6)
Indications (35)
Infectious disease (2960)
Inflammatory bowel disease (154)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (113)
Interviews (484)
IPO (16433)
IRA (51)
Job creations (4135)
Job search strategy (1850)
Kidney cancer (14)
Labor market (46)
Layoffs (556)
Leadership (25)
Legal (8419)
Liver cancer (82)
Lung cancer (399)
Lymphoma (193)
Machine learning (9)
Management (58)
Manufacturing (393)
MASH (90)
Medical device (14012)
Medtech (14017)
Mergers & acquisitions (21090)
Metabolic disorders (860)
Multiple sclerosis (100)
NASH (23)
Neurodegenerative disease (130)
Neuropsychiatric disorders (36)
Neuroscience (2200)
NextGen: Class of 2025 (6435)
Non-profit (3864)
Now hiring (38)
Obesity (459)
Opinion (274)
Ovarian cancer (95)
Pain (111)
Pancreatic cancer (105)
Parkinson's disease (180)
Partnered (22)
Patents (290)
Patient recruitment (137)
Peanut (52)
People (58460)
Pharmaceutical (99)
Pharmacy benefit managers (24)
Phase I (20832)
Phase II (29215)
Phase III (22417)
Pipeline (1586)
Policy (211)
Postmarket research (2656)
Preclinical (8778)
Press Release (71)
Prostate cancer (137)
Psychedelics (39)
Radiopharmaceuticals (263)
Rare diseases (479)
Real estate (6151)
Recruiting (65)
Regulatory (24012)
Reports (39)
Research institute (2418)
Resumes & cover letters (433)
Rett syndrome (9)
RNA editing (7)
RSV (51)
Schizophrenia (91)
Series A (157)
Series B (99)
Service/supplier (17)
Sickle cell disease (63)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (34)
Startups (3805)
State (2)
Stomach cancer (16)
Supply chain (77)
Tariffs (62)
The Weekly (86)
Vaccines (857)
Venture capitalists (51)
Weight loss (315)
Women's health (40)
Worklife (20)
Date
Last 7 days (505)
Last 30 days (2403)
Last 365 days (32757)
2025 (15524)
2024 (36115)
2023 (40654)
2022 (51742)
2021 (55935)
2020 (53829)
2019 (45809)
2018 (34784)
2017 (34098)
2016 (33668)
2015 (38521)
2014 (31568)
2013 (26586)
2012 (28751)
2011 (29242)
2010 (27070)
Location
Africa (862)
Alabama (58)
Alaska (7)
Arizona (230)
Arkansas (12)
Asia (43566)
Australia (7010)
California (7139)
Canada (2184)
China (654)
Colorado (302)
Connecticut (323)
Delaware (183)
Europe (96141)
Florida (1075)
Georgia (241)
Hawaii (1)
Idaho (57)
Illinois (612)
India (29)
Indiana (347)
Iowa (15)
Japan (216)
Kansas (104)
Kentucky (27)
Louisiana (12)
Maine (69)
Maryland (1029)
Massachusetts (5388)
Michigan (252)
Minnesota (430)
Mississippi (3)
Missouri (90)
Montana (31)
Nebraska (25)
Nevada (78)
New Hampshire (70)
New Jersey (2009)
New Mexico (30)
New York (1967)
North Carolina (1107)
North Dakota (9)
Northern California (3134)
Ohio (223)
Oklahoma (15)
Oregon (39)
Pennsylvania (1507)
Puerto Rico (17)
Rhode Island (32)
South America (1256)
South Carolina (33)
South Dakota (1)
Southern California (2650)
Tennessee (113)
Texas (1051)
United States (26610)
Utah (202)
Virginia (181)
Washington D.C. (74)
Washington State (617)
West Virginia (4)
Wisconsin (73)
704,961 Results for "avadel pharma flamel technologies s a acquired avadel".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 29, 2025
·
1 min read
Press Releases
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance
May 7, 2025
·
17 min read
Press Releases
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer
May 14, 2025
·
10 min read
Press Releases
Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
May 14, 2025
·
1 min read
Press Releases
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
May 29, 2025
·
15 min read
Press Releases
Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference
April 8, 2025
·
9 min read
Press Releases
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
June 5, 2025
·
10 min read
Press Releases
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7
April 30, 2025
·
1 min read
Press Releases
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
April 1, 2025
·
1 min read
Press Releases
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
March 5, 2025
·
1 min read
1 of 70,497
Next
